Edition:
United States

Zhangzhou Pientzehuang Pharmaceutical Ltd (600436.SS)

600436.SS on Shanghai Stock Exchange

72.38CNY
14 Feb 2018
Change (% chg)

¥0.45 (+0.63%)
Prev Close
¥71.93
Open
¥71.95
Day's High
¥72.66
Day's Low
¥71.80
Volume
2,633,446
Avg. Vol
5,949,102
52-wk High
¥77.77
52-wk Low
¥45.00

Chart for

About

ZHANGZHOUPIENTZEHUANG PHARMACEUTICAL .LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension,... (more)

Overall

Beta: 0.87
Market Cap(Mil.): ¥43,662.07
Shares Outstanding(Mil.): 603.32
Dividend: 0.27
Yield (%): 0.37

Financials

  Industry Sector
P/E (TTM): -- 32.03 17.27
EPS (TTM): -- -- --
ROI: -- 14.00 35.43
ROE: -- 15.34 17.10

BRIEF-Zhangzhou Pientzehuang Pharmaceutical's Prelim 2017 Net Profit Up 47.45 Percent Y/Y

Feb 6 Zhangzhou Pientzehuang Pharmaceutical Ltd :

Feb 06 2018

BRIEF-Zhangzhou Pientzehuang Pharmaceutical Sees 2017 Net Profit Up 40-60 Percent Y/Y

Jan 9 Zhangzhou Pientzehuang Pharmaceutical Ltd :

Jan 09 2018

BRIEF-Zhangzhou Pientzehuang Pharmaceutical passes review of high-tech enterprise recognition

* Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years since 2017

Jan 04 2018

BRIEF-Zhangzhou Pientzehuang Pharma's 9-month net profit up 40.3 pct y/y

Oct 26 Zhangzhou Pientzehuang Pharmaceutical Ltd * Says 9-month net profit up 40.3 percent y/y Source text in Chinese: http://bit.ly/2z9PX5m Further company coverage: (Reporting by Hong Kong newsroom)

Oct 26 2017

BRIEF-Zhangzhou Pientzehuang Pharmaceutical elects Liu Jianshun as chairman

Sept 25 Zhangzhou Pientzehuang Pharmaceutical Ltd

Sep 25 2017

BRIEF-Zhangzhou Pientzehuang Pharmaceutical's H1 net profit up 41.8 pct y/y

Aug 24 Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Aug 24 2017

Earnings vs. Estimates